Kurser indlæses...
Prognose
| Køb |
4 |
| Behold |
2 |
| Sælg |
0 |
Diskussioner i communityet
Der er endnu ingen diskussion om dette aktiv.
Start diskussionNyheder Til nyhedsfeedet
RELX confirms full-year guidance after nine-month revenue growth and continues share buyback
RELX reports an organic revenue increase of 7 percent for the first nine months and thus maintains growth into the third quarter. Management confirms the full-year guidance. The announced share buyback programme is extended by a further tranche of £125 million until early December. The stock is recovering from a February low after earlier weakness driven by concerns over AI. » Mere på finanzen.net
RELX confirms full-year guidance after 7% organic revenue increase and continues share buybacks
RELX reported 7% organic revenue growth for the first nine months and maintained that pace in the third quarter. Management confirmed the annual outlook and is continuing the share buyback program announced in February, with a further tranche of £125 million until early December. The stock eased slightly in London; earlier worries about the impact of artificial intelligence had weighed on the price. Over the past ten years the market value has more than doubled to almost £52 billion. » Mere på finanzen.net
RELX increases organic revenue and adjusted operating profit in first half of the year
The specialist publisher and database provider RELX reported organic revenue growth of 7 percent in the first six months to just under £4.9 billion. Adjusted operating profit rose organically by 9 percent to £1.7 billion and was broadly in line with analysts' expectations. CEO Erik Engstrom expects the positive trend to continue. The stock eased slightly after an initially strong session. » Mere på finanzen.net
RELX launches share buyback programme of £150 million
RELX has announced a new share buyback programme worth £150 million, running from today until 4 September 2026. The buyback follows the completion of a previously ended £100 million programme and is part of an overall £2.25 billion repurchase plan announced in February 2026. Purchased ordinary shares will be held as treasury shares; the repurchases will be carried out by ABN AMRO under an irrevocable instruction and within the limits approved by the general meeting. » Mere på de.investing.com
Relx rises after strong half-year and eased AI worries
Relx reported H1 2026 organic revenue growth of 7% to £4,871m and a 9% increase in adjusted operating profit to £1,727m; adjusted earnings per share rose 11% on a constant-currency basis. All four divisions contributed to growth, notably Legal with 10% organic revenue growth and a 13% rise in adjusted operating profit, driven by AI-powered tools such as Lexis+ and Protege. The adjusted operating margin improved by 70 basis points to 35.5% and the group confirmed its full-year outlook. The figures allayed concerns that third-party AI could threaten the Legal business and pushed the stock higher in pre-market trading. » Mere på de.investing.com
Historisk udbytte Udbytte
Alle nøgletal for udbytte Alle nøgletalVirksomhedstal
| (EUR) | juni 2026 | YoY |
|---|---|---|
| Omsætning | 4,84 mia. | - |
| Bruttofortjeneste | 3,1 mia. | - |
| Nettoresultat | 1,17 mia. | - |
| EBITDA | 1,95 mia. | - |
Fundamentale data
| Nøgletal | Værdi |
|---|---|
Markedsværdi | 62,37 mia. € |
Antal aktier | 1,74 mia. |
Højeste/laveste i 52 uger | 37,52 € - 23,08 € |
Udbytteafkast | 2,20 % |
Udbytte TTM | 0,80 € |
Beta | 0,26 |
P/E (PE Ratio) | 23,81 |
PEG (PEG Ratio) | 1,13 |
K/I (PB Ratio) | 43,29 |
P/S (PS Ratio) | 5,36 |
Virksomhedsprofil
RELX PLC leverer informationsbaserede analyser og beslutningsværktøjer til professionelle og erhvervskunder i Nordamerika, Europa og internationalt. Virksomheden opererer gennem fire segmenter: Risk; Scientific, Technical & Medical; Legal; og Exhibitions. Risk-segmentet tilbyder informationsbaserede analyser og beslutningsværktøjer, der kombinerer offentligt og branchespecifikt indhold med teknologi og algoritmer for at hjælpe kunder med at vurdere og forudsige risiko. Scientific, Technical & Medical-segmentet leverer information og analyser, der hjælper institutioner og fagfolk med at fremme videnskaben og udvikle sundhedsvæsenet. Legal-segmentet leverer juridisk, regulatorisk og forretningsmæssig information og analyser, som hjælper kunder med at træffe beslutninger og samtidig øger produktiviteten. Exhibitions-segmentet er aktiv inden for eventbranchen, hvor fysiske møder kombineres med data og digitale værktøjer, så kunder kan lære om markeder, finde produkter og gennemføre transaktioner. Virksomheden var tidligere kendt som Reed Elsevier PLC og skiftede navn til RELX PLC i juli 2015. Virksomheden blev stiftet i 1903 og har hovedkontor i London, Storbritannien.
| Navn | Relx Plc |
| CEO | Erik Engstrom |
| Hjemsted | London,
gl Storbritannien |
| Websted | |
| Sektor | Industrivirksomheder |
| Branche | Professionelle tjenester |
| Børsnotering | 01.07.1988 |
| Medarbejdere | 37.000 |
Tickersymboler
| Børs | Symbol |
|---|---|
Pnk | RLXXF |
London Stock Exchange | REL.L |
XETRA | RDEB.DE |
Euronext | REN.AS |
Amsterdam | REN.AS |
Frankfurt | RDEB.F |
Düsseldorf | RDEB.DU |
Hamburg | RDEB.HM |
London | REL.L |
SIX | RDEB.SW |
München | RDEB.MU |